Director
DIN: 10227204
Sanket Sudhakar Ingle is currently associated with 2 companies in various capacities such as Nominee and Designated Partner. They serve as a Director at BREECHCANDY NASIK HOSPITALS HEALTHCARE AND WELLNESS (OPC) PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10227204.Sanket Sudhakar Ingle is currently involved in 2 different roles. Their most recent position is with OLIMPUS DIALYSIS AND HEALTHCARE LLP as a Designated Partner. The first company Sanket Sudhakar Ingle was appointed to was BREECHCANDY NASIK HOSPITALS HEALTHCARE AND WELLNESS (OPC) PRIVATE LIMITED. Sanket Sudhakar Ingle is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sanket Sudhakar Ingle is currently associated with 2 companies in various capacities such as Nominee and Designated Partner. They serve as a Director at BREECHCANDY NASIK HOSPITALS HEALTHCARE AND WELLNESS (OPC) PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10227204.Sanket Sudhakar Ingle is currently involved in 2 different roles. Their most recent position is with OLIMPUS DIALYSIS AND HEALTHCARE LLP as a Designated Partner. The first company Sanket Sudhakar Ingle was appointed to was BREECHCANDY NASIK HOSPITALS HEALTHCARE AND WELLNESS (OPC) PRIVATE LIMITED. Sanket Sudhakar Ingle is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (1)
Current LLPs (1)
Past Companies (0)
1y 1m 7 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| BREECHCANDY NASIK HOSPITALS HEALTHCARE AND WELLNESS (OPC) PRIVATE LIMITED | Nominee | 04-May-2021 |